Clinical Trial

Association of Genetic Variants With Myopia

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to identify genetic factors linked to myopia, including those that influence a person's risk of developing it and how quickly it progresses (like changes in eye length). It will also examine how different treatments-such as low-dose atropine drops, orthokeratology lenses, specialized glasses, and increased outdoor time-interact with these genes. Finally, the research will develop a genetic risk score to help tailor personalized myopia prevention and treatment plans.
Trial Details
NCT Number NCT07030153
Lead Sponsor Beijing Visionly Plus Eye Hospital
Collaborators: Beijing New Vision Eye Hospital, High Myopia Control Alliance (HIMALAYA)
Conditions Myopia
Enrollment 1,000 participants
Start Date 2025-07-01
Primary Completion 2028-08-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-22